Evidence method
Level · gp.fundamentals.capex_revenue_ratio
10.29% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OVID · Dec 31, 2023
Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-009809General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-11687.90% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-73.93% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-15134.60% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7298.51% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1859.91% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 4.81%
- Current
- 10.29%
- Delta
- 5.48%
- Previous
- -9223.47%
- Current
- -11687.90%
- Delta
- -2464.43%
- Previous
- -11038.46%
- Current
- -15134.60%
- Delta
- -4096.14%
- Previous
- 4893.54%
- Current
- 7298.51%
- Delta
- 2404.96%
- Previous
- 1496.74%
- Current
- 1859.91%
- Delta
- 363.17%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · OVID Fundamental State →Has State · Ovid Therapeutics Inc. →Transitioned To · OVID CAPEX_INTENSITY_INCREASED →Transitioned To · OVID CASH_GENERATION_DECREASED →Transitioned To · OVID PROFITABILITY_DECREASED →Transitioned To · OVID R_AND_D_INTENSITY_INCREASED →Transitioned To · OVID SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.